Participants 62 100 3
laryngopharyngeal epidermoid carcinoma
Participants 136 267 7
Twenty-four patients, with a biopsy-proven laryngeal or hypopharyngeal carcinoma, received as an adjunct to their primary treatment
Participants 611 650 4
patients with laryngo-pharyngeal cancer
